What is TALi?
Founded in 2004, TALi has established itself as a leader in the intersection of neuroscience and digital health. The company specializes in the development of sophisticated software platforms designed to assess and treat cognitive performance issues in children. By integrating rigorous clinical research with highly engaging digital interfaces, TALi provides scalable solutions that assist children in overcoming developmental hurdles. Their core technology platform serves as a critical tool for educators and clinicians, effectively bridging the gap between complex neurological assessment and accessible, user-friendly mobile applications. As a key player in the B2B technology consulting space, TALi continues to refine its proprietary algorithms to ensure that its digital tools remain at the forefront of pediatric cognitive health.
How much funding has TALi raised?
TALi has raised a total of $1.5M across 1 funding round:
Private Equity
$1.5M
Private Equity (2025): $1.5M, investors not publicly disclosed
Key Investors in TALi
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for TALi?
With the successful completion of this major strategic investment, TALi is poised to scale its operations significantly. The company is expected to focus on expanding its market reach, potentially targeting international healthcare systems and educational institutions that require validated digital health solutions. Future growth will likely involve the enhancement of its existing software suite and the exploration of new therapeutic applications for its neuroscience-based platform. As the firm moves beyond its current development stage, the focus will shift toward long-term sustainability and the widespread adoption of its digital assessment tools, ensuring that its clinical impact matches its commercial ambition in the competitive global health-tech landscape.
See full TALi company page
